{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:46:28Z","timestamp":1794264388713,"version":"4.9.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jnma.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:27:16Z","timestamp":1774528036000},"page":"494-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Addressing disparities in transthyretin amyloid cardiomyopathy: A systematic review of artificial intelligence in the early identification to improve patient outcomes"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-8852","authenticated-orcid":false,"given":"Zihuang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4528-8254","authenticated-orcid":false,"given":"Natalie","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3227-6143","authenticated-orcid":false,"given":"Joe","family":"Abi-Rached","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4526-8777","authenticated-orcid":false,"given":"Aundria","family":"Parkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3191-8119","authenticated-orcid":false,"given":"Yitian","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3338-4410","authenticated-orcid":false,"given":"Keith C.","family":"Ferdinand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jnma.2026.03.004_bib0001","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ehf2.14337","article-title":"Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure","volume":"10","author":"Berthelot","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.jnma.2026.03.004_bib0002","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamacardio.2025.2948","article-title":"Transthyretin cardiac amyloidosis in older black and Hispanic individuals with heart failure","volume":"10","author":"Ruberg","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.jnma.2026.03.004_bib0003","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin Med L Engl"},{"issue":"2","key":"10.1016\/j.jnma.2026.03.004_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14797\/mdcvj.1070","article-title":"Light chain amyloidosis: epidemiology, staging, and prognostication","volume":"18","author":"Baker","year":"2022","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"2","key":"10.1016\/j.jnma.2026.03.004_bib0005","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/ehf2.13131","article-title":"Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan\u00ae in transthyretin wild-type cardiac amyloidosis","volume":"8","author":"Kharoubi","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.jnma.2026.03.004_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.012469","article-title":"Hereditary transthyretin cardiac amyloidosis with the p.V142I variant: mechanistic insights and diagnostic challenges","volume":"18","author":"Vanhentenrijk","year":"2025","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.jnma.2026.03.004_bib0007","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (transthyretin amyloid outcome survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jnma.2026.03.004_bib0008","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/genes16080960","article-title":"Hereditary transthyretin amyloidosis: genetic characterization of the TTR P.Val142Ile variant in a calabrian kindred","volume":"16","author":"Dinatolo","year":"2025","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.jnma.2026.03.004_bib0009","first-page":"322","article-title":"Canadian Cardiovascular Society\/Canadian Heart Failure Society joint position statement on the evaluation and management of patients with cardiac amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jnma.2026.03.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/17539447231216318","article-title":"The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis","volume":"17","author":"Kwok","year":"2023","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.jnma.2026.03.004_bib0011","series-title":"StatPearls","article-title":"Transthyretin amyloid cardiomyopathy (ATTR-CM)","author":"Jain","year":"2025"},{"issue":"Supplement_I","key":"10.1016\/j.jnma.2026.03.004_bib0012","doi-asserted-by":"crossref","first-page":"I131","DOI":"10.1093\/eurheartjsupp\/suac104","article-title":"The treatment of amyloidosis is being refined","volume":"24","author":"Cantone","year":"2022","journal-title":"Eur Heart J Suppl"},{"issue":"2","key":"10.1016\/j.jnma.2026.03.004_bib0013","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"issue":"10_Part_2","key":"10.1016\/j.jnma.2026.03.004_bib0014","article-title":"Early access to Tafamidis for patients with transthyretin amyloid cardiomyopathy","volume":"4","author":"Crespo-Leiro","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.jnma.2026.03.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2025.07.011","article-title":"Transthyretin amyloid cardiomyopathy: evolving therapies, expanding hope","author":"Costabel","year":"2025","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"10.1016\/j.jnma.2026.03.004_bib0016","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3390\/bioengineering10121435","article-title":"How Artificial intelligence is shaping medical imaging technology: a survey of innovations and applications","volume":"10","author":"Pinto-Coelho","year":"2023","journal-title":"Bioengineering"},{"issue":"4","key":"10.1016\/j.jnma.2026.03.004_bib0017","first-page":"118","article-title":"How artificial intelligence can enhance the diagnosis of cardiac amyloidosis: a review of recent advances and challenges","volume":"11","author":"Kamel","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"issue":"11","key":"10.1016\/j.jnma.2026.03.004_bib0018","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.mayocp.2021.04.023","article-title":"Artificial Intelligence-enhanced electrocardiogram for the early detection of cardiac amyloidosis","volume":"96","author":"Grogan","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jnma.2026.03.004_bib0019","article-title":"The role of artificial intelligence in the detection of cardiac amyloidosis: a systematic review","author":"Abdalla Ibrahim","year":"2025","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.jnma.2026.03.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036533","article-title":"Value of artificial intelligence for enhancing suspicion of cardiac amyloidosis using electrocardiography and echocardiography: a narrative review","volume":"14","author":"Grogan","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jnma.2026.03.004_bib0021","unstructured":"https:\/\/www.covidence.org\/."},{"issue":"1","key":"10.1016\/j.jnma.2026.03.004_bib0022","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1038\/s41467-021-22877-8","article-title":"Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms","volume":"12","author":"Goto","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.jnma.2026.03.004_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100612","article-title":"Postdevelopment performance and validation of the artificial intelligence-enhanced electrocardiogram for detection of cardiac amyloidosis","volume":"2","author":"Harmon","year":"2023","journal-title":"JACC Adv"},{"issue":"2","key":"10.1016\/j.jnma.2026.03.004_bib0024","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2589-7500(24)00249-8","article-title":"Artificial intelligence-guided detection of under-recognised cardiomyopathies on point-of-care cardiac ultrasonography: a multicentre study","volume":"7","author":"Oikonomou","year":"2025","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.jnma.2026.03.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.3436","article-title":"Artificial intelligence applied to electrocardiographic images for scalable screening of cardiac amyloidosis","volume":"45","author":"Sangha","year":"2024","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.jnma.2026.03.004_bib0026","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/heartjnl-2021-319846","article-title":"Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis","volume":"108","author":"Schrutka","year":"2022","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.jnma.2026.03.004_bib0027","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00259-024-06922-4","article-title":"Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis","volume":"52","author":"Shiri","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jnma.2026.03.004_bib0028","article-title":"International validation of echocardiographic AI amyloid detection algorithm","author":"Duffy","year":"2024","journal-title":"MedRxiv"},{"key":"10.1016\/j.jnma.2026.03.004_bib0029","article-title":"Tracking the preclinical progression of transthyretin amyloid cardiomyopathy using artificial intelligence-enabled electrocardiography and echocardiography","author":"Oikonomou","year":"2024","journal-title":"MedRxiv"},{"issue":"1","key":"10.1016\/j.jnma.2026.03.004_bib0030","article-title":"Deep learning supplants visual analysis by experienced operators for the diagnosis of cardiac amyloidosis by Cine-CMR","volume":"12","author":"Germain","year":"2021","journal-title":"Diagn Basel"},{"issue":"38","key":"10.1016\/j.jnma.2026.03.004_bib0031","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jnma.2026.03.004_bib0032","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12968-020-00690-4","article-title":"Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance","volume":"22","author":"Martini","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"issue":"12","key":"10.1016\/j.jnma.2026.03.004_bib0033","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/jpm11121268","article-title":"Convolutional neural networks for fully automated diagnosis of cardiac amyloidosis by cardiac magnetic resonance imaging","volume":"11","author":"Agibetov","year":"2021","journal-title":"J Pers Med"},{"issue":"11","key":"10.1016\/j.jnma.2026.03.004_bib0034","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcmg.2016.01.036","article-title":"Prognostic value of late gadolinium enhancement CMR in systemic amyloidosis","volume":"9","author":"Raina","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jnma.2026.03.004_bib0035","doi-asserted-by":"crossref","unstructured":"Chandramohan D, Rajasekaran R, Konda R, et al. Cardiac magnetic resonance imaging findings in patients with chronic kidney disease and end-stage kidney disease: a systematic review and meta-analysis. Cureus. 2024; 16(1):e51672. doi:10.7759\/cureus.51672.","DOI":"10.7759\/cureus.51672"},{"issue":"9","key":"10.1016\/j.jnma.2026.03.004_bib0036","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jamacardio.2018.2093","article-title":"Geographic disparities in reported US amyloidosis mortality from 1979 to 2015: potential underdetection of cardiac amyloidosis","volume":"3","author":"Alexander","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.jnma.2026.03.004_bib0037","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/phar.4639","article-title":"Disease-modifying therapies for amyloid transthyretin cardiomyopathy: current and emerging medications","volume":"45","author":"Hellenbart","year":"2025","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.jnma.2026.03.004_bib0038","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028534","article-title":"Design and rationale the SCAN-MP (screening for cardiac amyloidosis with nuclear imaging in minority populations) study","volume":"12","author":"Ruberg","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jnma.2026.03.004_bib0039","doi-asserted-by":"crossref","DOI":"10.70709\/rgj7pyq5g0","article-title":"Carpal tunnel syndrome secondary to amyloidosis deposition","volume":"IV","author":"Dunn","year":"2025","journal-title":"J Am Osteopath Acad Orthop"},{"issue":"8","key":"10.1016\/j.jnma.2026.03.004_bib0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0735-1097(23)00782-9","article-title":"Antiracist AI: a machine learning model using electrocardiograms and echocardiograms can detect transthyretin cardiac amyloidosis and decrease racial bias in diagnostic testing","volume":"81","author":"Jain","year":"2023","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968426000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968426000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:43:34Z","timestamp":1780407814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968426000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0027968426000520"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2026.03.004","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing disparities in transthyretin amyloid cardiomyopathy: A systematic review of artificial intelligence in the early identification to improve patient outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of National Medical Association.","name":"copyright","label":"Copyright"}]}}